Literature DB >> 17113330

Clinical assessment of chronic cough severity.

Anita A Raj1, Surinder S Birring.   

Abstract

The assessment of cough severity solely through consultation with the patient is limited by its subjective nature and variability of physician judgement. The assessment of cough has been hampered by a paucity of objective tools, those available have been poorly validated, non-standardized and are impractical for clinical use. Recent developments have overcome some of these problems and a variety of tools can now be used to assess cough that include visual analogue scales (VAS), quality-of-life questionnaires, cough reflex sensitivity measurement and automated cough frequency monitors. These tools can be used to validate the presence of cough and assess response to therapy. They will also have an important role in clinical trials.

Entities:  

Mesh:

Year:  2006        PMID: 17113330     DOI: 10.1016/j.pupt.2006.10.002

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  19 in total

1.  Evaluation of the efficacy of transcricoid lignocaine as adjunctive local anaesthesia for fiberoptic bronchoscopy.

Authors:  S Hamad; M Al-Alawi; N Devaney; A Subramaniam; S Lane
Journal:  Ir J Med Sci       Date:  2014-03-15       Impact factor: 1.568

2.  Outcome Measures for Clinical Trials in Interstitial Lung Diseases.

Authors:  Matthew R Lammi; Robert P Baughman; Surinder S Birring; Anne-Marie Russell; Jay H Ryu; Marybeth Scholand; Oliver Distler; Daphne LeSage; Catherine Sarver; Katerina Antoniou; Kristin B Highland; Otylia Kowal-Bielecka; Joseph A Lasky; Athol U Wells; Lesley Ann Saketkoo
Journal:  Curr Respir Med Rev       Date:  2015

3.  Cough and sleep.

Authors:  Kai K Lee; Surinder S Birring
Journal:  Lung       Date:  2009-10-13       Impact factor: 2.584

4.  Cough Aerosols of Mycobacterium tuberculosis in the Prediction of Incident Tuberculosis Disease in Household Contacts.

Authors:  Edward C Jones-López; Carlos Acuña-Villaorduña; Martin Ssebidandi; Mary Gaeddert; Rachel W Kubiak; Irene Ayakaka; Laura F White; Moses Joloba; Alphonse Okwera; Kevin P Fennelly
Journal:  Clin Infect Dis       Date:  2016-03-29       Impact factor: 9.079

5.  Cough aerosols of Mycobacterium tuberculosis predict new infection: a household contact study.

Authors:  Edward C Jones-López; Olive Namugga; Francis Mumbowa; Martin Ssebidandi; Olive Mbabazi; Stephanie Moine; Gerald Mboowa; Matthew P Fox; Nancy Reilly; Irene Ayakaka; Soyeon Kim; Alphonse Okwera; Moses Joloba; Kevin P Fennelly
Journal:  Am J Respir Crit Care Med       Date:  2013-05-01       Impact factor: 21.405

Review 6.  Use of specific neuromodulators in the treatment of chronic, idiopathic cough: a systematic review.

Authors:  Seth M Cohen; Stephanie Misono
Journal:  Otolaryngol Head Neck Surg       Date:  2013-01-08       Impact factor: 3.497

7.  ERS guidelines on the diagnosis and treatment of chronic cough in adults and children.

Authors:  Alyn H Morice; Eva Millqvist; Kristina Bieksiene; Surinder S Birring; Peter Dicpinigaitis; Christian Domingo Ribas; Michele Hilton Boon; Ahmad Kantar; Kefang Lai; Lorcan McGarvey; David Rigau; Imran Satia; Jacky Smith; Woo-Jung Song; Thomy Tonia; Jan W K van den Berg; Mirjam J G van Manen; Angela Zacharasiewicz
Journal:  Eur Respir J       Date:  2020-01-02       Impact factor: 16.671

8.  Cough frequency monitors: can they discriminate patient from environmental coughs?

Authors:  Stefan T Kulnik; Natalie M Williams; Lalit Kalra; John Moxham; Surinder S Birring
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

9.  The assessment of quality of life in acute cough with the Leicester Cough Questionnaire (LCQ-acute).

Authors:  Nadia Yousaf; Kai K Lee; Bhagyashree Jayaraman; Ian D Pavord; Surinder S Birring
Journal:  Cough       Date:  2011-07-18

10.  Sex and age differences in Mycobacterium tuberculosis infection in Brazil.

Authors:  P Fernandes; Y Ma; M Gaeddert; T Tsacogianis; P Marques-Rodrigues; G Fregona; A Loomans; E C Jones-López; R Dietze; J J Ellner; L F White; N S Hochberg
Journal:  Epidemiol Infect       Date:  2018-06-08       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.